No Bill#, Genomics and Personalized Medicine Act, Personalized medicine
Health information technology
Regulation and reimbursement of laboratory developed tests
Regulatory scienceNo Bill#, BETTER Patient Care Act
Whole genome sequencing
No Bill#, Genomics and Personalized Medicine Act, Personalized medicine
Health information technology
Regulation and reimbursement of laboratory-developed testsNo Bill#, BETTER Patient Care Act
Whole genome sequencing
Duration: April 1, 2009
to
May 31, 2011
General Issues: Health Issues , Medical/Disease Research/Clinical Labs , Food Industry (Safety, Labeling, etc.) , Science/Technology
Spending: about $380,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2009: House of Representatives, U.S. Senate, Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA), Natl Institutes of Health (NIH),, Natl Institutes of Health (NIH), State - Dept of (DOS), Natl Science Foundation (NSF)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
2nd Quarter, 2011
HealthFutures, LLC terminated an engagement in which they represented Life Technologies on July 12, 2011.
Original Filing: 300388122.xml
Lobbying Issues
No Bill#, Genomics and Personalized Medicine Act, Personalized medicine
Health information technology
Regulation and reimbursement of laboratory developed tests
Regulatory scienceNo Bill#, BETTER Patient Care Act
Whole genome sequencing
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) Food & Drug Administration (FDA) Natl Institutes of Health (NIH),
Lobbying Issues
No Bill#, Genomics and Personalized Medicine Act, Personalized medicine
Health information technology
Regulation and reimbursement of laboratory-developed testsNo Bill#, BETTER Patient Care Act
Whole genome sequencing
Agencies Lobbied
U.S. House of Representatives Food & Drug Administration (FDA) U.S. Senate Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2011
In Q1, HealthFutures, LLC lobbied for Life Technologies , earning $40,000. The report was filed on April 18, 2011.
Original Filing: 300366203.xml
Lobbying Issues
No Bill#, Genomics and Personalized Medicine Act, Personalized medicine
Health information technology
Regulation and reimbursement of laboratory developed tests
Regulatory scienceNo Bill#, BETTER Patient Care Act
Whole genome sequencing
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) Food & Drug Administration (FDA) Natl Institutes of Health (NIH),
Lobbying Issues
No Bill#, Genomics and Personalized Medicine Act, Personalized medicine
Health information technology
Regulation and reimbursement of laboratory-developed testsNo Bill#, BETTER Patient Care Act
Whole genome sequencing
Agencies Lobbied
U.S. House of Representatives Food & Drug Administration (FDA) U.S. Senate Natl Institutes of Health (NIH)
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2010
In Q4, HealthFutures, LLC lobbied for Life Technologies , earning $50,000. The report was filed on Jan. 18, 2011.
Original Filing: 300340658.xml
Lobbying Issues
HR 5440, Genomics and Personalized Medicine Act, Personalized medicine
HR 805, Strengthening America's Public Health System Act, Pandemic influenza
Regulation and reimbursement of laboratory developed tests
Regulatory scienceNo Bill#, BETTER Patient Care Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) Food & Drug Administration (FDA) Natl Institutes of Health (NIH),
Lobbying Issues
HR 5440, Genomics and Personalized Medicine Act, Personalized medicine
No Bill#, Genomic Research and Accessibility Act, DNA patents
HR 805, Strengthening America's Public Health System Act, Pandemic influenza
No Bill#, BETTER Patient Care Act
Agencies Lobbied
U.S. House of Representatives Food & Drug Administration (FDA) U.S. Senate State - Dept of (DOS)
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2010
In Q3, HealthFutures, LLC lobbied for Life Technologies , earning $50,000. The report was filed on Oct. 15, 2010.
Original Filing: 300313656.xml
Lobbying Issues
HR 5440, Genomics and Personalized Medicine Act, Personalized medicine
HR 805, Strengthening America's Public Health System Act, Pandemic influenza
Regulation and reimbursement of laboratory developed tests
Regulatory science
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) Food & Drug Administration (FDA) Natl Institutes of Health (NIH),
Lobbying Issues
HR 5440, Genomics and Personalized Medicine Act, Personalized medicine
No Bill#, Genomic Research and Accessibility Act, DNA patents
HR 805, Strengthening America's Public Health System Act, Pandemic influenza
Agencies Lobbied
U.S. House of Representatives Food & Drug Administration (FDA) U.S. Senate State - Dept of (DOS)
Type of Issue
Medical/Disease Research/Clinical Labs
2nd Quarter, 2010
In Q2, HealthFutures, LLC lobbied for Life Technologies , earning $50,000. The report was filed on July 19, 2010.
Original Filing: 300291045.xml
Lobbying Issues
HR 5440, Genomics and Personalized Medicine Act, Personalized medicine
HR 805, Strengthening America's Public Health System Act, Pandemic influenza
Regulation and reimbursement of laboratory developed tests
Regulatory science
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) Food & Drug Administration (FDA) Natl Institutes of Health (NIH) Natl Science Foundation (NSF)
Lobbying Issues
HR 5440, Genomics and Personalized Medicine Act, Personalized medicine
No Bill#, Genomic Research and Accessibility Act, DNA patents
HR 805, Strengthening America's Public Health System Act, Pandemic influenza
HR 5116, America Competes Reauthorization Act, bioscience research program at NISTS. 1649, Weapons of Mass Destruction Prevention and Preparedness Act, pandemic influenza
Agencies Lobbied
U.S. House of Representatives Food & Drug Administration (FDA) U.S. Senate
Type of Issue
Medical/Disease Research/Clinical Labs
1st Quarter, 2010
In Q1, HealthFutures, LLC lobbied for Life Technologies , earning $50,000. The report was filed on April 15, 2010.
Original Filing: 300259515.xml
Lobbying Issues
No Bill#, Genomics and Personalized Medicine Act, Personalized medicine
HR 3590, Patient Protection and Affordable Care Act, Pandemic influenza
HR 805, Strengthening America's Public Health System Act, Pandemic influenza
Regulation and reimbursement of laboratory developed testsRegulatory science
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) Food & Drug Administration (FDA) Natl Institutes of Health (NIH) Natl Science Foundation (NSF)
Lobbying Issues
No Bill#, Genomics and Personalized Medicine Act, Personalized medicine
No Bill#, Genomic Research and Accessibility Act, DNA patents
HR 805, Strengthening America's Public Health System Act, Pandemic influenza
Agencies Lobbied
U.S. House of Representatives Food & Drug Administration (FDA)
Type of Issue
Medical/Disease Research/Clinical Labs
4th Quarter, 2009
In Q4, HealthFutures, LLC lobbied for Life Technologies , earning $50,000. The report was filed on Jan. 15, 2010.
Original Filing: 300233016.xml
Lobbying Issues
Personalized medicine
Health Care Reform, Comparative effectiveness research
Pandemic influenza
Regulation of laboratory developed tests
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) Food & Drug Administration (FDA) Natl Institutes of Health (NIH)
Lobbying Issues
No bill#, Genomics and Personalized Medicine Act
DNA patents
Agencies Lobbied
U.S. House of Representatives Food & Drug Administration (FDA)
Type of Issue
Medical/Disease Research/Clinical Labs
3rd Quarter, 2009
In Q3, HealthFutures, LLC lobbied for Life Technologies , earning $40,000. The report was filed on Oct. 16, 2009.
Original Filing: 300207893.xml
Lobbying Issues
Personalized medicine
Health Care Reform, Comparative effectiveness research
Pandemic influenza
Regulation of laboratory developed tests
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
No bill#, Genomics and Personalized Medicine Act
Agencies Lobbied
U.S. House of Representatives Food & Drug Administration (FDA)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Pathogen detection
S 510, FDA Food Safety Modernization Act
HR 759, Food and Drug Administration Globalization Act.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Food Industry (Safety, Labeling, etc.)
2nd Quarter, 2009
In Q2, HealthFutures, LLC lobbied for Life Technologies , earning $30,000. The report was filed on July 16, 2009.
Original Filing: 300179738.xml
Lobbying Issues
Personalized medicine
Health Care Reform, Comparative effectiveness research
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
No bill#, Genomics and Personalized Medicine Act
Agencies Lobbied
U.S. House of Representatives Food & Drug Administration (FDA)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Pathogen detection
S. 510, FDA Food Safety Modernization Act
HR 759, Food and Drug Administration Globalization Act.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Food Industry (Safety, Labeling, etc.)
2nd Quarter, 2009
HealthFutures, LLC filed a lobbying registration on April 12, 2009 to represent Life Technologies, effective April 1, 2009.
Original Filing: 300146695.xml
Issue(s) they said they’d lobby about: Issues related to the adoption of personalized medicine; food safety and testing; genomics research .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate